Exact Mass: 452.2787266

Tribendimidine

C28H32N6 (452.26883119999997)

Tribendimidine is an orally active, broad-spectrum anthelmintic agent, with particularly high activity against A. lumbricoides and N. americanus. Tribendimidine is also an L-type nicotinic acetylcholine receptor (nAChR) agonist[1][2][3].

1-Cycloheptyl-1-(9H-fluoren-2-ylmethyl)-3-(2,4,6-trimethylphenyl)urea

C31H36N2O (452.2827486)

DG(2:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

C25H40O7 (452.277389)

DG(2:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/2:0/0:0)

C25H40O7 (452.277389)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(2:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

C25H40O7 (452.277389)

DG(2:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/2:0)

C25H40O7 (452.277389)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(2:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

C25H40O7 (452.277389)

DG(2:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/2:0/0:0)

C25H40O7 (452.277389)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(2:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

C25H40O7 (452.277389)

DG(2:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/2:0)

C25H40O7 (452.277389)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(2:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

C25H40O7 (452.277389)

DG(2:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/2:0/0:0)

C25H40O7 (452.277389)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(2:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

C25H40O7 (452.277389)

DG(2:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/2:0)

C25H40O7 (452.277389)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

Antiostatin B3

C26H36N4O3 (452.2787266)

Antiostatin B4

C26H36N4O3 (452.2787266)

Briarellin P

C25H40O7 (452.277389)

Laserpitinol

C25H40O7 (452.277389)

methyl-13S-hydroxy-14R,15-diacetoxy-1(10)-ent-halimen-18-oate

C25H40O7 (452.277389)

grindelic acid 15-O-arabinoside

C25H40O7 (452.277389)

14,15-Di-Ac,17-Me ester-13,14,15-Trihydroxy-7-labden-17-oic acid

C25H40O7 (452.277389)

Ecdysteron

C25H40O7 (452.277389)

C25H40O7

C25H40O7 (452.277389)

dothideomycetone B

C25H40O7 (452.277389)

5,6-acetonylgrayanotoxin-I

C25H40O7 (452.277389)

18-methylmalonyl-7alpha-hydroxy-methyltrineracetal

C25H40O7 (452.277389)

6alpha,8alpha,23,14,15-erythro-pentahydroxy-labd-13(21),17-dien-16,19-olide|6alpha,8alpha,23,14,15-threo-pentahydroxy-labd-13(21),17-dien-16,19-olide

C25H40O7 (452.277389)

6beta,7beta,11beta,14beta,15beta-pentahydroxy-20-isoamoxy-7alpha,20-epoxy-ent-kaur-16-ene|hebeirubescensin F

C25H40O7 (452.277389)

Tomentin

C25H40O7 (452.277389)

Ala His Ile Ile

C21H36N6O5 (452.2747046)

Ala His Ile Leu

C21H36N6O5 (452.2747046)

Ala His Leu Ile

C21H36N6O5 (452.2747046)

Ala His Leu Leu

C21H36N6O5 (452.2747046)

Ala Ile His Ile

C21H36N6O5 (452.2747046)

Ala Ile His Leu

C21H36N6O5 (452.2747046)

Ala Ile Ile His

C21H36N6O5 (452.2747046)

Ala Ile Leu His

C21H36N6O5 (452.2747046)

Ala Leu His Ile

C21H36N6O5 (452.2747046)

Ala Leu His Leu

C21H36N6O5 (452.2747046)

Ala Leu Ile His

C21H36N6O5 (452.2747046)

Ala Leu Leu His

C21H36N6O5 (452.2747046)

His Ala Ile Ile

C21H36N6O5 (452.2747046)

His Ala Ile Leu

C21H36N6O5 (452.2747046)

His Ala Leu Ile

C21H36N6O5 (452.2747046)

His Ala Leu Leu

C21H36N6O5 (452.2747046)

His Ile Ala Ile

C21H36N6O5 (452.2747046)

His Ile Ala Leu

C21H36N6O5 (452.2747046)

His Ile Ile Ala

C21H36N6O5 (452.2747046)

His Ile Leu Ala

C21H36N6O5 (452.2747046)

His Leu Ala Ile

C21H36N6O5 (452.2747046)

His Leu Ala Leu

C21H36N6O5 (452.2747046)

His Leu Ile Ala

C21H36N6O5 (452.2747046)

His Leu Leu Ala

C21H36N6O5 (452.2747046)

His Val Val Val

C21H36N6O5 (452.2747046)

Ile Ala His Ile

C21H36N6O5 (452.2747046)

Ile Ala His Leu

C21H36N6O5 (452.2747046)

Ile Ala Ile His

C21H36N6O5 (452.2747046)

Ile Ala Leu His

C21H36N6O5 (452.2747046)

Ile His Ala Ile

C21H36N6O5 (452.2747046)

Ile His Ala Leu

C21H36N6O5 (452.2747046)

Ile His Ile Ala

C21H36N6O5 (452.2747046)

Ile His Leu Ala

C21H36N6O5 (452.2747046)

Ile Ile Ala His

C21H36N6O5 (452.2747046)

Ile Ile His Ala

C21H36N6O5 (452.2747046)

Ile Leu Ala His

C21H36N6O5 (452.2747046)

Ile Leu His Ala

C21H36N6O5 (452.2747046)

Leu Ala His Ile

C21H36N6O5 (452.2747046)

Leu Ala His Leu

C21H36N6O5 (452.2747046)

Leu Ala Ile His

C21H36N6O5 (452.2747046)

Leu Ala Leu His

C21H36N6O5 (452.2747046)

Leu His Ala Ile

C21H36N6O5 (452.2747046)

Leu His Ala Leu

C21H36N6O5 (452.2747046)

Leu His Ile Ala

C21H36N6O5 (452.2747046)

Leu His Leu Ala

C21H36N6O5 (452.2747046)

Leu Ile Ala His

C21H36N6O5 (452.2747046)

Leu Ile His Ala

C21H36N6O5 (452.2747046)

Leu Leu Ala His

C21H36N6O5 (452.2747046)

Leu Leu His Ala

C21H36N6O5 (452.2747046)

Val His Val Val

C21H36N6O5 (452.2747046)

Val Val His Val

C21H36N6O5 (452.2747046)

Val Val Val His

C21H36N6O5 (452.2747046)

Sarcoehrendin I

C25H40O7 (452.277389)

1-Propanol, 2-methoxy-3-[(9Z)-9-octadecenyloxy]-, dihydrogen phosphorothioate, (2R)

C22H45O5PS (452.27251700000005)

1-hexadecyl-3-methylimidazolium hexafluorophosphate

C20H39F6N2P (452.2754896)

R 5011 (dopant)

C32H36O2 (452.2715156)

1-Cycloheptyl-1-(9H-fluoren-2-ylmethyl)-3-(2,4,6-trimethylphenyl)urea

C31H36N2O (452.2827486)

YM-750 is a potent acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor (IC50=0.18 μM). ACAT catalyzes the formation of cholesteryl esters from cholesterol and long-chain fatty-acyl-coenzyme A[1][2].

Butropium

C28H38NO4+ (452.28006880000004)

C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent

N-hexadecanoyl-sn-glycero-3-phosphoethanolamine(1-)

C21H43NO7P- (452.27769980000005)

DG(2:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

C25H40O7 (452.277389)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/2:0/0:0)

C25H40O7 (452.277389)

DG(2:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

C25H40O7 (452.277389)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/2:0)

C25H40O7 (452.277389)

DG(2:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

C25H40O7 (452.277389)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/2:0/0:0)

C25H40O7 (452.277389)

DG(2:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

C25H40O7 (452.277389)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/2:0)

C25H40O7 (452.277389)

DG(2:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

C25H40O7 (452.277389)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/2:0/0:0)

C25H40O7 (452.277389)

DG(2:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

C25H40O7 (452.277389)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/2:0)

C25H40O7 (452.277389)

Ala-Leu-Leu-His

C21H36N6O5 (452.2747046)

A tetrapeptide composed of L-alanine, two L-leucine units, and an L-histidine joined in sequence.

epiandrosterone 3-beta-D-glucoside

C25H40O7 (452.277389)

A sterol 3-beta-D-glucoside that has epiandrosterone as the sterol component.

2-[[(2R)-2-acetyloxy-3-undec-10-enoxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C21H43NO7P+ (452.27769980000005)

2-[hydroxy-[2-hydroxy-3-[(Z)-tridec-9-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C21H43NO7P+ (452.27769980000005)

lysophosphatidylethanolamine zwitterion 16:0

C21H43NO7P (452.27769980000005)

A lysophosphatidylethanolamine zwitterion in which the remaining acyl group (position not specified) contains 16 carbons and 0 double bonds.

ST 19:0;O;GlcA

C25H40O7 (452.277389)

ST 19:1;O2;Hex

C25H40O7 (452.277389)

ST 25:2;O7

C25H40O7 (452.277389)

(1s,2s,3r,4r,7r,8r,11s,14r,15r,17s)-15-hydroxy-14-methoxy-4,8,11,15-tetramethyl-9-oxo-10,18-dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadecan-4-yl butanoate

C25H40O7 (452.277389)

(2s)-2-{[(2s)-2-{[(2s)-2-{[(2s)-2-amino-1-hydroxypropylidene]amino}-1-hydroxy-4-methylpentylidene]amino}-1-hydroxy-4-methylpentylidene]amino}-3-(3h-imidazol-4-yl)propanoic acid

C21H36N6O5 (452.2747046)

12,12-dimethyl-16-(3-methylbutoxy)-6-methylidene-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecane-3,7,9,10,18-pentol

C25H40O7 (452.277389)

15-hydroxy-14-methoxy-4,8,11,15-tetramethyl-9-oxo-10,18-dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadecan-4-yl butanoate

C25H40O7 (452.277389)

(1r,2s,3s,5s,7r,8r,9s,10s,11r,16s,18r)-12,12-dimethyl-16-(3-methylbutoxy)-6-methylidene-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecane-3,7,9,10,18-pentol

C25H40O7 (452.277389)

1-[(4ar,5r,6s,7r,8ar)-7-hydroxy-5-{2-[(3s,5s)-5-methoxyoxolan-3-yl]ethyl}-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]methyl 3-methyl propanedioate

C25H40O7 (452.277389)

(1r,4ar,5s,8s,8ar)-5-[(3r)-3-hydroxy-3-methylpent-4-en-1-yl]-1,4a,6-trimethyl-8-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}-2,3,4,5,8,8a-hexahydronaphthalene-1-carbaldehyde

C25H40O7 (452.277389)

1-[(4ar,5r,6s,7r,8ar)-7-hydroxy-5-{2-[(3s,5r)-5-methoxyoxolan-3-yl]ethyl}-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]methyl 3-methyl propanedioate

C25H40O7 (452.277389)

1-{7-hydroxy-5-[2-(5-methoxyoxolan-3-yl)ethyl]-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl}methyl 3-methyl propanedioate

C25H40O7 (452.277389)

(1s,2e,4s,6e)-1-[(1r,2s,5r,6s)-5-hydroxy-4-(hydroxymethyl)-2-[(2-hydroxypropan-2-yl)oxy]-7-oxabicyclo[4.1.0]hept-3-en-1-yl]-3,7,11-trimethyldodeca-2,6,10-triene-1,4-diol

C25H40O7 (452.277389)

(1r,2s,5r,6s)-1-[(1s,2e,4s,6e)-1,4-dihydroxy-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]-4-{[(2-hydroxypropan-2-yl)oxy]methyl}-7-oxabicyclo[4.1.0]hept-3-ene-2,5-diol

C25H40O7 (452.277389)

5-(3-hydroxy-3-methylpent-4-en-1-yl)-1,4a,6-trimethyl-8-[(3,4,5-trihydroxyoxan-2-yl)oxy]-2,3,4,5,8,8a-hexahydronaphthalene-1-carbaldehyde

C25H40O7 (452.277389)

(1s,2s,3r,4r,7r,8r,11s,14r,15r,17r)-15-hydroxy-14-methoxy-4,8,11,15-tetramethyl-9-oxo-10,18-dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadecan-4-yl butanoate

C25H40O7 (452.277389)